The Supreme Court closed the misleading advertisements case against Patanjali, observing that once manufacturing of a product is permitted, its advertisement becomes a natural business practice, providing relief to the company after months of legal scrutiny.
Today, On 7th March, The Supreme Court is set to issue comprehensive directions for enforcing the Drugs and Magic Remedies Act. The case stems from a writ petition by the Indian Medical Association (IMA). The IMA seeks action against misleading advertisements promoting allopathic medicines. The ruling aims to curb false medical claims and protect public health.